Pharmesis International LtdPharmesis International Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Check the end of this page for potential risks for Pharmesis International Ltd based on sector, geography and marketcap. This ESG rating covers seventeen UN SDGs including: 'No Poverty', 'Climate Action' and 'Partnerships for the Goals'. This Sustainability assessment for Pharmesis International Ltd represents its reporting of the UN SDGs.

Pharmesis International Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.6; made up of an environmental score of 0.0, social score of 2.7 and governance score of 8.0.

SDG Transparency Score for Pharmesis International Ltd 

3.6

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Pharmesis International Ltd 
0.0

Environmental

2.7

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
.........
1132Taro Pharmaceutical Industries Ltd
3.7
Medium
1132Traphaco JSC
3.7
Medium
1144Pharmesis International Ltd
3.6
Medium
1144CellSeed Inc
3.6
Medium
1144Cellectar Biosciences Inc
3.6
Medium
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Pharmesis International Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Pharmesis International Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Pharmesis International Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Pharmesis International Ltd offer flexible work?

LockedSign up for free to unlock

Does Pharmesis International Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Pharmesis International Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Pharmesis International Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose water use targets?

LockedSign up for free to unlock

Does Pharmesis International Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Pharmesis International Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Pharmesis International Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Pharmesis International Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Pharmesis International Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Pharmesis International Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Pharmesis International Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Pharmesis International Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Pharmesis International Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Pharmesis International Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Pharmesis International Ltd
These potential risks are based on the size, segment and geographies of the company.

Pharmesis International Ltd., an investment holding company, researches, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People's Republic of China. The company provides prescribed products and over-the-counter drugs. It offers western medicine products under the Kinna brand, including Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Compound Procaine hydrochloride to treat arteriosclerosi, menopausal symptoms, dyspepsia, and adynamia; Lianpushuangqing for acute inflammation; AFenKa to treat migraine, pain, headache, nasosinusitis, cold, muscle pain, menstrual pain, toothache, and arthritis; Xiao Shi Jian Pi to treat flatus, inappetency, dyspepsy, and spleen weakness; and Xiao Luo Tong for the rheumatoid arthritis and other rheumatic diseases treatment. The company also provides TCM formulated products under the Longlife brand name comprising Gulin Gansu for acute and chronic hepatitis treatment; Er Ding granules to treat jaundice, and clear heat and toxics; and Kang Gu Zeng Sheng for boosting the functions of kidney, as well as for increasing blood circulation and alleviating pain. In addition, it offers health supplement products, such as Mei Li Wei Ta to combat aging process and support bone health for women; Hao Xiu Xi to enhance sleep and regulate blood fats; Hao Zhuang Tai to regulate blood fats and fight fatique; and Qianlieman'an for promoting healthy prostate function and colon health, and supporting urinary function, as well as SHULINGHOU for the treatment of acute and chronic pharyngitis, laryngitis, sore throat, and hoarseness. Further, the company engages in the wholesale of chemical drugs, biological raw products, TCM products, antibiotics, and antibiotic agents. Pharmesis International Ltd. was founded in 1996 and is based in Singapore.

Sorry!

Failed to process!